But next year, investors will be watching how the dominant players in the market, Novo Nordisk and Eli Lilly, navigate supply issues plaguing their treatments
Also see our articles about benzene in sunscreens and deodorants
Semaglutide is administered subcutaneously (under the skin, not into muscle) once weekly, typically in the abdomen, thigh, or upper arm
4 fl oz
[124] A common approach involves reducing the dose by approximately 10-25% every 1-2 weeks, though individualization may be necessary
According to the FDA prescribing information, gastrointestinal adverse reactions are very common, with nausea (24-37%), diarrhea (18-26%), vomiting (8-25%), and constipation (16-24%) occurring frequently across clinical trials